-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Georg Hess1*, Vladan Vucinic, M.D.2*, Kai Rejeski, MD3, Enver Aydilek4*, Linda Simon, MD5*, Olaf Penack, MD6*, Christian Koenecke, MD7, Malte von Bonin, MD8*, Bastian von Tresckow, MD9, Martin Fehr, MD10*, Christiane Pott11*, Stephan Stilgenbauer, MD12, Corinna Leng, MD, PhD13*, Roland Schroers, MD14*, Johannes Duell, MD15*, Reinhard Marks, MD16*, Fabian Mueller, MD17*, Uta Brunnberg, MD18*, Andrea Kerkhoff, MD19*, Anke Ohler5*, Eva-Maria Wagner Drouet20*, Irene Schmidtmann21*, Matthias Theobald, MD20, Martin Dreyling, MD22 and Peter Dreger, MD23

1University Clinic Mainz, Mainz, Germany
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany
3University of Munich, LMU, Munich, Germany
4Universtity of Goettingen, Goettingen, Germany
5University Medical School of the Johannes Gutenberg-University, Mainz, Germany
6Department of Hematology, Oncology, and Cancer Immunology, Charité Universitätsmedizin Berlin, Campus Virchow Klinik, Berlin, Germany
7Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, NDS, Germany
8Department of Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany
9Cancer Center Cologne Essen (CCCE), Cologne / Essen, Germany
10Division of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
11Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
12Department of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany
13Charité, Berlin, DEU
14Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany, Bochum, Germany
15Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany
16Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
17Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Bavaria, Germany
18University of Frankfurt, Frankfurt, DEU
19Medical Department A for Hematology, Oncology, and Pneumology, University Hospital Muenster, Muenster, Germany
20Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
21Institute of Epidemiology, Biometry and Statistics, Mainz, Germany
22Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany
23Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany

Charles Milrod, MD1, Kang Woo Kim2*, Thomas Ollila, MD2, Adam J Olszewski, MD2 and Ari Pelcovits, MD3

1Department of Hematology & Oncology, Brown University, Boston, MA
2Brown University, Providence, RI
3Lifespan Cancer Institute, Legoretta Cancer Center of Brown University, Providence, RI

Ahmed Ludvigsen Al-Mashhadi1*, Mikkel Runason Runason Simonsen, MSc2*, Chan Yoon Cheah, MD3, Rose-Marie Amini4*, Bente Arboe5*, James R. Cerhan, MD, PhD6, Iman Chanchiri7*, Michael Roost Clausen, MD, PhD8*, Jonathan Day9*, Toby A. Eyre10*, Anne Ortved Gang5*, Herve Ghesquieres, MD11*, Thomas M. Habermann, MD6, Eliza A Hawkes, MD12, Steven R. Hwang, MD6, Jennifer B Jørgensen13*, Arushi Khurana, MBBS14, Claire Maquet15*, Ng Layshe, MD14*, Stephen S. Opat, MBBS, FRACP, FRCPA16, Martin Bjerregård Pedersen, MD, PhD17*, Christian Bjørn Poulsen18*, Alexandros Rampotas10*, Andreea Sima4*, Karin Ekstroem Smedby, MD, PhD19*, Knut Smeland20*, Elizabeth Smyth21*, Gita Thanarajasingam, MD6, Judith Trotman, MBChB, FRACP, FRCPA22, Katharine Xing23*, Simon Østergaard18*, Diego Villa, MD24 and Tarec C El-Galaly25*

1Department of Hematology, Aalborg University Hospital, Viborg, Denmark
2Department of Hematology, Aalborg University Hospital, Aalborg, AL, Denmark
3Linnear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Australia
4Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
5Department of Hematology, Rigshospitalet, Copenhagen, Denmark
6Division of Hematology, Mayo Clinic, Rochester, MN
7Department of Hematology, Odense University Hospital, Odense, Denmark
8Department of Hematology, Vejle Hospital, Vejle, DNK
9University of Iowa, Iowa City, IA
10Department of Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
11Lyon Sud Hospital, Lyon, France
12School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
13Department of Internal Medicine, Haematology section, Goedstrup Hospital, Herning, Denmark
14Mayo Clinic, Rochester, MN
15Department of Hematology, Lyon Sud Hospital, Lyon, France
16Lymphoma and Related Diseases Registry, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
17Dept. of Hematology, Aarhus University Hospital, Aarhus C, Region Midt, DNK
18Department of Hematology, Zealand University Hospital, Roskilde, Denmark
19Clinical Epidemiology Division, Department of Medicine Solna,, Karolinska Institutet, Stockholm, Sweden
20Department of Oncology, Oslo University Hospital, Oslo, Norway
21Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
22Concord Repatriation General Hospital, University of Sydney, Sydney, Australia
23BC Cancer, Surrey, Canada
24Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
25Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

Ryan C Lynch, MD1,2, Christina Poh, MD3, Mazyar Shadman, MD, MPH3, Brian G Till3, Stephen D Smith, MD3, Chaitra S Ujjani, MD3, Susan Ottemiller1*, Melissa Mary Fessel, ANP, BSN, RN1*, Bonnie Joy1*, Jacob DeBell1*, Joshua Dizon3*, Ryan Park1*, Heather Rasmussen2*, Jacquelin Vandermeer, BS3*, Jenna M Voutsinas, MPH4* and Ajay K Gopal, MD3

1Fred Hutch Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Fred Hutchinson Cancer Center, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Enrico Tiacci1*, Luca De Carolis1*, Monia Capponi1*, Flavio Falcinelli1*, Francesco Zaja, MD2,3*, Alessandro Pulsoni, MD4*, Edoardo Simonetti1*, Elisa Montechiarello5*, Alessandra Romano, MD6*, Jacopo Olivieri7*, Alessandro Mancini8*, Gianna Maria D'Elia9*, Robin Foa10*, Maurizio Frezzato11* and Brunangelo Falini1

1Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy
2DSM, University of Trieste, Trieste, Italy
3UCO Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
4Hematology, University Sapienza, S.M. Goretti Hospital, Latina, Italy
5Hematology, Hospital of Reggio Calabria, Italy, Reggio Calabria, Italy
6Hematology, University and Hospital of Catania, Italy, Catania, ITA
7Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
8Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, PERUGIA, Italy
9Hematology, University Sapienza and Hospital Umberto I, Rome, Rome, Italy
10Hematology, University Sapienza and Hospital Umberto I, Rome, Italy
11Hematology, Hospital of Vicenza, Italy, Vicenza, ITA

Alessandro Pulsoni, MD1*, Maria Elena Tosti, Statistician2*, Simone Ferrero, MD3, Stefano Luminari, MD4, Alessandra Dondi5*, Anna Marina Liberati, MD6, Natalia Cenfra, MD7*, Daniela Renzi, MD8*, Manuela Zanni, MD9*, Carola Boccomini, MD10*, Andrés José María Ferreri, MD11, Sara Rattotti, MD12*, Vittorio Ruggero Zilioli13*, Patrizia Bernuzzi, MD14*, Silvia Bolis, MD15*, Gerardo Musuraca, MD, PhD16*, Luca Nassi, MD17*, Tommasina Perrone, MD18*, Caterina Stelitano19*, Antonella Anastasia, MD20*, Paolo Corradini, MD21, Giovanni Partesotti, MD22*, Francesca Re, MD23*, Emanuele Cencini, MD24*, Clara Mannarella25*, Donato Mannina, MD26*, Anna Lia Molinari, MD27*, Monica Tani28*, Giorgia Annechini, MD29*, Giovanni Manfredi Assanto30*, Lavinia Grapulin, MD31*, Anna Guarini, PhD32*, Marzia Cavalli, PhD30*, Lucia Anna De Novi, PhD30*, Riccardo Bomben33*, Elena Ciabatti, PhD34*, Barbara Mantoan, PhD35*, Daniela Drandi35*, Irene Della Starza, PhD30,36*, Luca Arcaini12*, Umberto Ricardi, MD37*, Valter Gattei, MD38, Sara Galimberti, MD, PhD39*, Marco Ladetto40, Robin Foà, MD32* and Ilaria Del Giudice29*

1Hematology, Sapienza University - Polo Pontino, Department of Translational and Precision Medicine, S.M. Goretti Hospital, Latina, Italy
2Istituto Superiore di Sanità, National Center for Global Health, Rome, Italy
3Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU “Città della Salute e della Scienza di Torino”, Torino, Italy
4Hematology Unit, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale - IRCCS, University of Modena and Reggio Emilia, Reggio Emilia, Italy
5Fondazione Italiana Linfomi Onlus (FIL), Modena, Italy
6Oncohematology Unit, Azienda Ospedaliera Santa Maria di Terni, University, Perugia, Italy
7Hematology Unit, S. Maria Goretti Hospital , AUSL Latina, Latina, Italy
8Hematology and Stem Cells Transplantation Unit, IRCCS Istituto Nazionale dei Tumori Regina Elena, Rome, Italy
9Division of Hematology, SS. Antonio e Biagio Hospital, Alessandria, Italy
10Hematology Department, Città della Salute e della Scienza, Turin, Italy
11Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
12Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
13Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, IT-MI, Italy
14Hematology Unit, Guglielmo da Saliceto Hospital,, Department of Onco-Hematology, Piacenza, Italy
15Hematology Department, ASST San Gerardo University Hospital, Monza, Italy
16Hematology Unit, Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori-IRST, Meldola, Italy
17Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
18Unit of Hematology with Transplantation, University of Bari, Dept. of Emergency and Organ Transplantation, Bari, Italy
19Department of Hematology, Azienda Ospedaliera Bianchi Melacrinò Morelli, Reggio Calabria, Reggio Calabria, Italy
20Hematology, ASST Spedali Civili, Brescia, Italy
21Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
22Onco-Hematology Department, Nuovo ospedale civile of Sassuolo, Sassuolo, Italy
23UO Ematologia e CTMO, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
24Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
25Hematology Unit, Ospedale Madonna delle Grazie, Matera, Italy
26Division of Hematology, Azienda Ospedaliera Papardo, Messina, Messina, Italy
27Hematology, Ospedale degli Infermi, Rimini, Italy
28Division of Hematology, Santa Maria delle Croci Hospital, Ravenna, Italy
29Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
30Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
31Department of Radiotherapy, Policlinico Umberto I, Sapienza University, Rome, Italy
32Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
33CRO Aviano National Cancer Institute,Clinical and Experimental Onco-Hematology Unit, Aviano, Italy
34Section of Hematology, University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy
35Hematology Division, University of Torino/AOU "Città della Salute e della Scienza di Torino", Department of Molecular Biotechnologies and Health Sciences, Turin, Italy
36AIL Roma Odv, Rome, Italy
37Department of Oncology, University of Torino, Torino, Italy
38Centro Di Riferimento Oncologico, Aviano, Italy
39Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
40Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Yuqin Song, MD1, Qingqing Cai, PhD2*, Ming Jiang3*, Keshu Zhou, MD4*, Lei Zhang, MD5*, Xiuhua Sun6*, Zhengming Jin, B.S.7*, Lanfang Li8*, Hongmei Jing9, Zhigang Peng, MD10*, Haiyan Yang11, Junyuan Qi, MD12*, Hui Zhou13*, Wei Yang, MD14*, Min Zhou15*, Chunyan Ji, md, phd16, Wei Xu17*, Kaiyang Ding18*, Li Yu19*, Zheng Wang20*, Nawei Liu20*, Yejiang Lou20*, Yue Shen, PhD20*, Yi Chen, PhD21*, Fenlai Tan20* and Jun Zhu22*

1Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
2Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
3The State Key Laboratory of Pathogenesis and Prevention of Central Asian High Incidence Diseases, Urumqi, China
4Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
5Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
6The Second Hospital of Dalian Medical University, Dalian, China
7Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
8Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
9Peking University Third Hospital, Beijing, China
10Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
11Zhejiang Cancer Hospital, Hangzhou, China
12Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China
13Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
14Shengjing Hospital of China Medical University, Shenyang, China
15Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
16Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
17Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
18Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
19The Second Affiliated Hospital of Nanchang University, Nanchang, China
20Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
21Newave Pharmaceutical Inc., Pleasanton, CA
22Department of Lymphoma, Peking University Cancer Hospital and Institute, BEIJING, China

John F. Seymour, MBBS, PhD, FRACP1, Chan Yoon Cheah, MD2,3,4, Ricardo Parrondo, MD5, Meghan C. Thompson, MD6, Don A. Stevens, MD7, Masa Lasica8*, Michael L. Wang, MD9, Abhijeet Kumar10*, Judith Trotman, FRACP11, Maan Alwan12*, Wei Ding, MD, PhD13, Kunthel By, PhD14*, Bilal Tariq14*, Xiangmei Chen15*, Shannon Fabre14*, Jason Paik14*, Amit Agarwal16* and Constantine S. Tam, MD, MBBS17,18*

1Peter Maccallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, AUS
2Department of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, Western Australia, Australia
3Medical School, University of Western Australia, Crawley, Western Australia, Australia
4Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
5Mayo Clinic, Jacksonville, FL
6Memorial Sloan Kettering Cancer Center, New York, NY
7Norton Cancer Institute, Louisville, KY
8Department of Haematology, St Vincent’s Hospital Melbourne, Victoria, Australia, Fitzroy, VIC, Australia
9MD Anderson Cancer Center, Houston, TX
10University of Arizona College of Medicine – Tucson, Tucson, AZ
11Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
12Perth Blood Institute, West Perth, Western Australia, Australia
13Mayo Clinic-Rochester, Rochester, MN
14BeiGene USA, Inc, San Mateo, CA
15BeiGene (Shanghai) Co, Ltd, Shanghai, China
16BeiGene, San Mateo, CA
17Alfred Hospital, Melbourne, VIC, Australia
18Monash University, Clayton, VIC, Australia

Ira Miller1*, Daniel Jose Arenas, PhD1*, Melanie Mumau2*, Michael V. Gonzalez3* and David C. Fajgenbaum, MD, MBA, MSc2

1Center for Cytokine Storm & Treatment Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Zainab Shahid1,2*, Michelle Okwali, MPH3*, Ashlee Joseph4*, Susan K. Seo, MD5,6*, Jennifer Kimberly Lue7*, Alexander P. Boardman8*, Philip Caron, MD9, Kevin A. David, MD3*, Zachary D. Epstein-Peterson, MD9, Paola Ghione, MD, MSEpi7, Paul A. Hamlin, MD3, Steven M. Horwitz, MD7, Andrew M. Intlekofer, MD, DPhil9, William Johnson7*, Anita Kumar, MD10, Alison Moskowitz, MD7, Ariela Noy, MD3, Colette Owens, MD9, Maria Lia Palomba, MD3, Robert Stuver, MD7, Pallawi Torka, MD9, Santosha A Vardhana, MD, PhD3*, Andrew D. Zelenetz, MD, PhD9, Gilles Salles, MD, PhD3 and Lorenzo Falchi, MD3

1Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Weill Cornell Medicine, New York, NY
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
4Memorial Sloan Kettering Cancer Center, New York
5Department of Medicine, Weill Cornell Medicine, New York
6Department of Medicine, Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
10Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ

Mark Orland, MD1, Michael Sheu, MD1*, Meera Patel, MD1*, Bridget Adcock, MD1*, Valentina Ardila, MD2*, Gautam Shrivastava, MD1*, Sofia Molina Garcia, MD1* and Aneela Majeed, MD3*

1Internal Medicine, Cleveland Clinic, Cleveland, OH
2Internal Medicine, Cleveland Clinic, Cleveland
3Infectious Disease, Cleveland Clinic, Cleveland, OH

Maria Poza Santaella1*, Rodrigo Íñiguez2*, Irene Zamanillo3*, Tycho S. Baumann1*, Antonia Rodriguez Izquierdo1*, Enrique Revilla, MD4*, Sandra Gomez Rojas1*, Gloria Perez Segura1*, Pilar Martinez Sanchez, M.D.5*, Carlos Grande, MD, PhD6*, Pilar Sarandeses7*, Santiago Barrio, PhD8*, Maria Calbacho1*, Rosa Ayala, MD1*, Joaquin Martinez-Lopez, MD, PhD1* and Ana Jimenez Ubieto9*

1Hospital Universitario 12 de Octubre, Madrid, Spain
2Hospital Universitario 12 De Octubre, Madrid, Spain
3University Hospital 12 de Octubre, Madrid, Spain
4Departamento de Anatomia Patologica, Hospital Universitario 12 de Octubre, Madrid, Spain
5Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
6Clínica Universidad de Navarra, Madrid, Spain
7Departamento de Medicina Nuclear, Hospital Universitario 12 de Octubre, Madrid, Spain
8Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
9Hospital Universitario 12 de Octubre, MADRID, MADRID, Spain

Elham Askari1*, David F. Moreno2*, Fernando Escalante3*, Amalia Domingo-González4*, Angela Heredia5*, Arancha Bermúdez6*, Miguel Canales7*, Mario Arnao Herraiz8*, Maria Magdalena Alcala Peña9*, Ana Saus Carreres10*, Pablo Ríos Rull11*, María Casanova12*, Mercedes Gironella13*, Paz Ribas Garcia14*, Javier De La Rubia15*, Belén Navarro16*, María-Jesús Blanchard17*, Cristina Motlló18*, Ricarda García Sánchez19*, Francisco Taboada Alameda20*, Antonio Garcia21*, Eugenio Abella22*, Miguel Angel Alvarez Rivas23*, Joan Bargay24*, Laura Abril Sabater25*, Amanda Lopez Picado26*, Carlos Fernández de Larrea2* and Ramon Garcia-Sanz27

1Department of Hematology, Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain
2Hospital Clínic de Barcelona, Barcelona, Spain
3Hospital Universitario de Leon, Leon, Spain
4Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain
5Hospital Virgen de la Arrixaca, Murcia, Spain
6Hospital Marques de Valdecilla, Santander, Spain
7Clínica Universidad de Navarra Cancer Center (CCUN), Pamplona, Spain
8Hospital La Fe, Valencia, Spain
9Hospital general de Malaga, Malaga, Spain
10Hospital Clínico de Valnecia, Valencia, Spain
11Hospital Ntra. Sra. de Candelaria, Sta. Cruz De Tenerife, ESP
12Hospital Costa Del Sol Marbella, Marbella, Spain
13Hospital Universitari Vall d'Hebron, Barcelona, Spain
14Hospital Dr. Peset, Valencia, Spain
15Hospital Universitario y Politécnico La Fe, Valencia, Spain
16Hospital Universitario Puerta de Hierro, Majadahonda, Spain
17Hospital Universitario Ramón y Cajal, Madrid, Spain
18Hospital Sant Joan de Déu de Manresa, Barcelona, Spain
19Hospital Virgen de la Victoria, Malaga, Spain
20Hospital Vital Alvarez Buylla, Oviedo, Spain
21Hospital Arnau de Villanova, Lleida, Spain
22Hospital del Mar, Barcelona, Spain
23Hospital Reina Sofia, Madrid, Spain
24Hospital Universitario Son Llàtzer. IdIsBa., Palma de Mallorca, Spain
25Institut Català d’Oncologia, Badalona, Spain
26Sociedad Española de Hematologia, Madrid, Spain
27Department of Hematology, University Hospital of Salamanca, Salamanca, Spain

Danielle McQuinn, MD1, Meredith Hyun, MS2*, KyungMann Kim, PhD3*, Vaishalee P Kenkre, MD1, Christopher D Fletcher, MD1*, Saurabh A Rajguru, MD1*, Priyanka A Pophali, MD1, Mariah Endres4*, Mitch Howard4*, Tim Wassenaar, MD, MS5, Ruth Callaway Warren, MD6*, Ryan J Mattison, MD1, Kari B Wisinski, MD1* and Julie E Chang, MD7

1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
2Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison, WI
3Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI
4University of Wisconsin Carbone Cancer Center, Madison, WI
5ProHealth Care, Waukesha, WI
6Green Bay Oncology, St. Vincent Regional Cancer Center, Green Bay, WI
7Department of Medicine, University of Wisconsin, Madison, WI

Disha Dalela, MBBS1, Rahul Lakhotia, MBBS1, Stefania Pittaluga, MD, PhD2*, Jagan R. Muppidi, MD, PhD1*, James D Phelan, PhD1*, Amynah Pradhan, NP1*, Sarah Evans, RN1*, Candis Morrison, NP, PhD1*, Atekelt Tadese, PA1*, Seth M. Steinberg, PhD3*, Jeffrey Cohen4*, Elaine S. Jaffe, MD5, Wyndham H Wilson, MD, PhD1*, Mark Roschewski, MD1 and Christopher Melani, MD1

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
3Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
4Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
5CCR Lab of Pathology, National Cancer Institute, Bethesda, MD

Lauren Banner1*, Thomas Z Rohan, BS1*, Rachel Zachian, MD1*, Tyler Gross, BS1*, Daniel Joffe1*, Pierluigi Porcu, MD2,3 and Neda Nikbakht, MD1*

1Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
2Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
3Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA

Loretta J. Nastoupil, MD1, Gilles Salles, MD, PhD2, John P. Leonard3, Frank Morschhauser4, Kylee Jordan Veazey5, Valerie Perrot6*, Vitalii Doban6*, Marion Bonnet6*, Alexandra Z. Sosinsky7*, Aaron Crowley7*, Camryn Lieb7*, Zhengfan Wang7*, Bret Zeldow7*, Joanna Harton7*, Shu Wang7* and Tamer Garawin5*

1MD Anderson Cancer Center, Houston, TX
2Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Weill Cornell Medicine, New York, NY
4Centre Hospitalier Régional Universitaire de Lille, Lille, France
5Ipsen Biopharmaceuticals, Cambridge, MA
6Ipsen Pharma, Boulogne-Billancourt, France
7Genesis Research, Hoboken, NJ

Gao Yan, PhD1, Jianqiu Wu, PhD2*, Yunhong Huang3*, Hui Zhou4, Ru Feng5*, Fei Li6*, Xue-Ping Li7*, Xiaoxiao Wang8*, Bing Bai8*, Yu-Hua Huang9*, Haixia He1*, Liqin Ping8*, Yanxia He10*, Cheng Huang8*, Jibin Li11*, Jiaying Mao12* and Huiqiang Huang, MD, PhD13

1Sun Yat-Sen University Cancer Center, Guangzhou, China
2Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China
3The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
4Hunan Cancer Hospital, Changsha, China
5Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China, Guangdong, China
6The First Affiliated Hospital of Nanchang University, Nanchang, China
7Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
8Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
9Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, AL, China
10Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
11Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China
12Sun Yat-Sen University Cancer Center, Guangzhou, CHN
13Department of Medical Oncology, Sun Yat-Sen Univ. Cancer Ctr., Guangzhou, Guangdong, China

Victoria A. Vardell, MD1, Boyu Hu, MD1, Lindsey Fitzgerald, MD1, Harsh Shah, DO1, Allison M. Bock, MD1, Deborah M. Stephens, DO1 and Daniel A. Ermann, MD2

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2Huntsman Cancer Institute, University of Utah, Omaha, NE

David Jacob Hermel, MD, Anna Ter-Zakarian, MD, Jacob New, MD, PhD* and Alan Saven, MD*

Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA

Francesco Angotzi1*, Simone Zoletto, MD1*, Alessandro Cellini, MD1*, Chiara Cavaretta, MD1*, Valeria Ruocco, MD1*, Ivan Zatta, MD1*, Laura Forlani, MD1*, Andrea Serafin, MD1*, Roberta Bertorelle2*, Federica Frezzato, PhD1*, Marco Pizzi, MD3*, Andrea Padoan4*, Daniela Basso4*, Giovanni Pizzolo, MD5*, Livio Trentin1 and Andrea Visentin, MD, PhD1*

1Hematology Unit, Department of Medicine, University of Padova, Padova, Italy
2Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV-IRCCS), Padova, ITA
3Department of Medicine, Surgical Pathology and Cytopathology Unit, University of Padova, Padua, Italy
4Department of Integrated Diagnostic Medicine, Laboratory Medicine Unit, University of Padova, Padova, Italy
5Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy

Saishravan Shyamsundar1*, Mateo Sarmiento Bustamante, BA2*, Sheila K. Pierson, MSc2*, Joshua D. Brandstadter, MD, PhD2,3*, Frits van Rhee, MD, PhD4 and David C. Fajgenbaum, MD, MBA, MSc2*

1Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA
2Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Yingtong Chen*, Ping Yang*, Jing Wang*, Shuang Gao*, Xiaoyan Ke* and Hongmei Jing, MD

Peking University Third Hospital, Beijing, China

Fenghua Gao1*, Jing Liu1*, Jiesong Wang1*, Lihong Liu2*, Zhiming Li3*, Yuqin Song, MD4, Xudong Zhang5*, Hui Zhou6*, Xiuhua Sun7*, Wei Zhang8*, Bing Xu9*, Liping Su10*, Wen Shujuan11*, Rong Tao, MD, PhD12*, Ou Bai, MD/PhD13*, Qingyuan Zhang14*, Liqun Zou, MD, PhD15*, Xianhuo Wang1* and Huilai Zhang16*

1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
2The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
3State Key Laboratory of Oncology in South China, Guangzhou, China
4Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
5The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
6Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
7The Second Hospital of Dalian Medical University, Dalian, China
8Peking Union Medical College Hospital, Beijing, China
9The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen, China
10Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Taiyuan, Shanxi, CHN
11Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China
12Fudan University Shanghai Cancer Center, Shanghai, China
13Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China
14Harbin Medical University Cancer Hospital, Harbin, China
15West China Hospital of Sichuan University, Chengdu, China
16Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, China

Chunyuan Li1*, Jingjing Yin2*, Yue Yuan3*, Ping Yang1*, Hui Liu2* and Hongmei Jing, MD4

1Peking University Third Hospital, Beijing, China
2Beijing Hospital, Beijing, China
3Acornmed Biotechnology Co., Ltd., Beijing, China
4Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China

Adrian Mosquera Orgueira, MD, PhD1*, Alba Carbita2*, Victor Navarro Garces3*, Pau Abrisqueta, MD, PhD4, Rodrigo Alonso Salcedo Pereda5*, Carlos Aliste Santos6*, Marta Canelo Vilaseca, MD7*, Marina Gomez Rosa, MD8*, Alberto Lopez Garcia, MD9*, Tomas Garcia, MD, PhD10*, Fatima De la Cruz, MD11*, Juan-Manuel Sancho, MD, PhD12*, Eduardo Rios Herranz, MD8*, Raul Cordoba, MD, PhD13, Angel Serna, MD14*, Gloria Iacoboni, MD15*, Moraima Jiménez, MD16*, Cecilia Carpio17*, Cristina Garcia16*, Josep Castellvi, MD18*, Francesc Bosch, MD, PhD19 and Ana Marin Niebla, MD, PhD16*

1University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
2Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Hematology Department, Barcelona, Spain
3Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
5University Hospital of Santiago de Compostela, Deparment of Hematology, IDIS, Santiago de Compostela, Spain
6University Hospital of Santiago De Compostela, SANTIAGO DE COMPOSTELA, ESP
7Hematology Department, University Hospital Germans Trias i Pujol, Badalona, Spain
8Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
9Hematology Department, University Hospital Fundación Jiménez Díaz, Madrid, Spain
10Hematology Department, University Hospital Arnau de Vilanova, Lleida, Spain
11Hematology Department, University Hospital Virgen del Rocío, Seville, Spain
12Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
13Fundacion Jimenez Diaz University Hospital, Madrid, Spain
14Hematology Department,, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
15Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, SEATTLE, WA
16Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
17University Hospital Vall d’Hebron, Barcelona, Spain
18Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain
19Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain

Daniel Park, DO1, Won Jin Jeon, MD2, Bowon Joung, MD2*, Bryan Pham, MD, MMSc2, Christopher Hino, MD2*, Jae Lee, BS3*, Chieh Yang, MD4*, Esther G Chong, MD5, Akhil Mehta, DO6*, Jin Hyun Moon, MD6*, Andrea Shields, MD6*, Anthony Nguyen, MD7*, Joel Brothers, MD8*, Yan Liu, MD9*, Mojtaba Akhtari, MD8, Ke K Zhang, PhD10*, Huynh Cao, MD11* and Dani Ran Castillo, MD12*

1Department of Internal Medicine, University of California San Francisco-Fresno, Fresno, CA
2Department of Internal Medicine, Loma Linda University, Loma Linda, CA
3Loma Linda University School of Medicine, Loma Linda, CA
4University of California Riverside, Riverside, CA
5Division of Hematology and Oncology, Department of Internal Medicine, Loma Linda University, Loma Linda, CA
6Department of Internal Medicine, Loma Linda University, Loma Linda
7Hematology/Oncology, University of California, San Diego, San Diego
8Department of Hematology/Oncology, Loma Linda University, Loma Linda
9Loma Linda University, Loma Linda, CA
10Nutrition, Texas A&M University, College Station
11Department of Hematology and Oncology, Department of Internal Medicine, Loma Linda University, Loma Linda, CA
12Division of Hematology/Oncology, City of Hope, Duarte, CA

Muhammad Junaid Tariq, MBBS1, Andrea Carolina Anampa-Guzmán, MD1*, Malak Alharbi, MD1*, Khalid Shalaby, MBBCh1, Riya Patel, MBBS1, Showkat Hamid, MD2*, Anthony George, MS1*, Kristopher Attwood, PhD, MS3*, Francisco J. Hernandez-Ilizaliturri, MD4 and Matthew J Cortese, MD, MPH1

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY

Burak Karakaya, MD1*, Boran Yavuz, MD2* and Fatih Demirkan, MD2

1Department of Internal Medicine, Dokuz Eylul University, Izmir, Turkey
2Division of Hematology, Dokuz Eylul University, Izmir, Turkey

Ping Yang*, Shuozi Liu*, Weilong Zhang*, Jing Wang* and Hongmei Jing

Peking University Third Hospital, Beijing, China

John G. Gribben, MD, DSc1, Emmanuel Bachy, MD, PhD2*, Markqayne Ray, PharmD3*, Kathryn Krupsky, PhD4*, Kathleen Beusterien, MPH4*, Lewis Kopenhafer, BA4*, Flor Mendez, PhD4*, Sara Beygi, MD5*, Timothy Best, PhD3*, Graeme Ball, MSc3*, Kacper Perkowski, MS4*, Patrick Olsen, MPH4*, Anik R Patel, PhD5* and Paola Ghione, MD6*

1Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
2Haematology Department, Hospices Civils de Lyon, Pierre-Bénite, Lyon, France
3Kite, a Gilead Company, Santa Monica, CA
4Real World Evidence, Cerner Enviza, an Oracle Company, Kansas City, MO
5Kite, A Gilead Company, Santa Monica, CA
6Cancer Center, Memorial Sloan Kettering, New York, NY

Nagapratap Ganta, MD1*, Varsha Gupta, MBBS2, Fnu Anamika, MD1*, Akshit Chitkara, MD3*, Sheilabi Seeburun4* and Ruchi Bhatt4*

1Hackensack Meridian Ocean University Medical Center, Brick, NJ
2Jersey Shore University Medical Center, Neptune, NJ
3University of California Riverside, San Bernardino, CA
4Jersey Shore University Medical Center, Neptune

Mohammed Almakadi, MBBS, Muhammad Rehan Akram*, Dalal Aldhafeeri*, Ahmed Alrajjal*, Ahmed Elazony*, Azhar Nawaz*, Mohammed Alruwaythi*, Hamoud Althubyani*, Amal Albeihany* and Liju Ahmed*

King Faisal Specialist Hospital and Research Center - Madinah, Madinah, Saudi Arabia

Yangzhi Zhao, MD/PhD1*, Wei Guo1*, Jia Li1, Xingtong Wang, MD2, Xin Wan, MD1*, Junna Li, MD3* and Ou Bai, MD/PhD4*

1Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China
2Department of Hematology, The First Hospital of Jilin University, Changchun, KY, China
3Department of Hematology, The first hospital of Jilin University, Changchun, Jilin, China
4The First Hospital of Jilin University, Changchun, Jilin, China

*signifies non-member of ASH